STOCK TITAN

[D] Kindly MD, Inc. SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
D
Rhea-AI Filing Summary

Kindly MD, a Utah-based healthcare company focused on hospitals and physicians, has filed Form D for an exempt securities offering under Rule 506(b). The company has successfully completed a $711.7 million offering, with the entire amount already sold to 156 investors.

Key details of the offering include:

  • Sales commissions of $20.6 million and finder's fees of $293,400
  • Cohen & Company Capital Markets and Anthem Securities LLC serving as brokers, receiving equity fees of 2% and 0.5% respectively of post-closing common stock
  • Offering includes equity, debt, and options/warrants
  • Connected to a business combination transaction (merger/acquisition)

The company's leadership includes Timothy Pickett as CEO and Director, with other executives Jared Barrera and Adam Cox. The board includes Amy Powell, Christian Robinson, and Gary Seelhorst. The offering was marketed across multiple states including California, New York, Texas, and international markets.

Kindly MD, un'azienda sanitaria con sede nello Utah focalizzata su ospedali e medici, ha presentato il Modulo D per un'offerta di titoli esenti ai sensi della Regola 506(b). L'azienda ha completato con successo un'offerta di 711,7 milioni di dollari, con l'intero importo già venduto a 156 investitori.

I dettagli principali dell'offerta includono:

  • Commissioni di vendita per 20,6 milioni di dollari e commissioni di intermediazione per 293.400 dollari
  • Cohen & Company Capital Markets e Anthem Securities LLC come broker, che ricevono commissioni azionarie rispettivamente del 2% e dello 0,5% delle azioni ordinarie post-chiusura
  • L'offerta comprende azioni, debito e opzioni/warrant
  • Collegata a una transazione di combinazione aziendale (fusione/acquisizione)

La leadership dell'azienda include Timothy Pickett come CEO e Direttore, con altri dirigenti Jared Barrera e Adam Cox. Il consiglio di amministrazione è composto da Amy Powell, Christian Robinson e Gary Seelhorst. L'offerta è stata promossa in diversi stati, tra cui California, New York, Texas, e mercati internazionali.

Kindly MD, una empresa de salud con sede en Utah enfocada en hospitales y médicos, ha presentado el Formulario D para una oferta de valores exentos bajo la Regla 506(b). La compañía ha completado con éxito una oferta de 711,7 millones de dólares, con el monto total ya vendido a 156 inversores.

Los detalles clave de la oferta incluyen:

  • Comisiones de venta de 20,6 millones de dólares y honorarios de intermediación de 293.400 dólares
  • Cohen & Company Capital Markets y Anthem Securities LLC actuando como corredores, recibiendo comisiones de capital del 2% y 0,5% respectivamente sobre las acciones ordinarias posteriores al cierre
  • La oferta incluye capital, deuda y opciones/warrants
  • Vinculada a una transacción de combinación empresarial (fusión/adquisición)

El liderazgo de la empresa incluye a Timothy Pickett como CEO y Director, con otros ejecutivos Jared Barrera y Adam Cox. La junta directiva incluye a Amy Powell, Christian Robinson y Gary Seelhorst. La oferta se comercializó en varios estados, incluyendo California, Nueva York, Texas y mercados internacionales.

Kindly MD는 유타에 본사를 둔 병원 및 의사 중심의 헬스케어 회사로, 규칙 506(b)에 따른 면제 증권 공모를 위해 Form D를 제출했습니다. 회사는 7억 1,170만 달러 규모의 공모를 성공적으로 완료했으며, 전체 금액이 이미 156명의 투자자에게 판매되었습니다.

공모의 주요 내용은 다음과 같습니다:

  • 판매 수수료 2,060만 달러 및 중개 수수료 293,400달러
  • Cohen & Company Capital Markets와 Anthem Securities LLC가 중개인으로 활동하며, 각각 종결 후 보통주에 대해 2% 및 0.5%의 지분 수수료를 받음
  • 공모에는 주식, 부채 및 옵션/워런트가 포함됨
  • 기업 결합 거래(합병/인수)와 연계

회사의 경영진에는 CEO 겸 이사인 Timothy Pickett을 비롯해 Jared Barrera와 Adam Cox가 있으며, 이사회에는 Amy Powell, Christian Robinson, Gary Seelhorst가 포함되어 있습니다. 이 공모는 캘리포니아, 뉴욕, 텍사스 및 국제 시장 등 여러 주에서 마케팅되었습니다.

Kindly MD, une société de santé basée dans l'Utah, axée sur les hôpitaux et les médecins, a déposé le formulaire D pour une offre de titres exemptée selon la règle 506(b). La société a réussi à clôturer une offre de 711,7 millions de dollars, le montant total ayant déjà été vendu à 156 investisseurs.

Les détails clés de l'offre comprennent :

  • Commissions de vente de 20,6 millions de dollars et frais d'intermédiation de 293 400 dollars
  • Cohen & Company Capital Markets et Anthem Securities LLC agissant en tant que courtiers, recevant des commissions en actions de 2 % et 0,5 % respectivement sur les actions ordinaires post-clôture
  • L'offre comprend des actions, des dettes et des options/garanties
  • Liée à une opération de fusion-acquisition

La direction de la société comprend Timothy Pickett en tant que PDG et administrateur, avec d'autres cadres Jared Barrera et Adam Cox. Le conseil d'administration inclut Amy Powell, Christian Robinson et Gary Seelhorst. L'offre a été commercialisée dans plusieurs états, notamment en Californie, à New York, au Texas, ainsi que sur des marchés internationaux.

Kindly MD, ein im US-Bundesstaat Utah ansässiges Gesundheitsunternehmen mit Fokus auf Krankenhäuser und Ärzte, hat das Formular D für ein von der Registrierung befreites Wertpapierangebot gemäß Regel 506(b) eingereicht. Das Unternehmen hat erfolgreich ein Angebot über 711,7 Millionen US-Dollar abgeschlossen, wobei der gesamte Betrag bereits an 156 Investoren verkauft wurde.

Wichtige Details des Angebots umfassen:

  • Verkaufsprovisionen in Höhe von 20,6 Millionen US-Dollar und Vermittlungsgebühren von 293.400 US-Dollar
  • Cohen & Company Capital Markets und Anthem Securities LLC fungieren als Broker und erhalten Eigenkapitalgebühren von 2 % bzw. 0,5 % des Post-Closing-Stammkapitals
  • Das Angebot umfasst Eigenkapital, Schulden sowie Optionen/Warrants
  • Im Zusammenhang mit einer Unternehmenszusammenschluss-Transaktion (Fusion/Übernahme)

Die Unternehmensführung besteht aus Timothy Pickett als CEO und Direktor sowie weiteren Führungskräften Jared Barrera und Adam Cox. Der Vorstand setzt sich aus Amy Powell, Christian Robinson und Gary Seelhorst zusammen. Das Angebot wurde in mehreren Bundesstaaten, darunter Kalifornien, New York, Texas, sowie auf internationalen Märkten beworben.

Positive
  • Successfully completed a significant $711.7M securities offering, fully subscribed with 156 investors
  • Secured notable institutional support with Cohen & Company Capital Markets and Anthem Securities as placement agents
  • Business combination transaction (merger/acquisition) in progress, indicating strategic growth initiatives
  • Strong geographic presence with operations approved across multiple major states including California, New York, Texas, and Florida
Negative
  • High sales commissions and finder's fees totaling approximately $20.9M (nearly 3% of raised amount)
  • Additional equity dilution through 2.5% post-closing stock compensation to placement agents

Kindly MD, un'azienda sanitaria con sede nello Utah focalizzata su ospedali e medici, ha presentato il Modulo D per un'offerta di titoli esenti ai sensi della Regola 506(b). L'azienda ha completato con successo un'offerta di 711,7 milioni di dollari, con l'intero importo già venduto a 156 investitori.

I dettagli principali dell'offerta includono:

  • Commissioni di vendita per 20,6 milioni di dollari e commissioni di intermediazione per 293.400 dollari
  • Cohen & Company Capital Markets e Anthem Securities LLC come broker, che ricevono commissioni azionarie rispettivamente del 2% e dello 0,5% delle azioni ordinarie post-chiusura
  • L'offerta comprende azioni, debito e opzioni/warrant
  • Collegata a una transazione di combinazione aziendale (fusione/acquisizione)

La leadership dell'azienda include Timothy Pickett come CEO e Direttore, con altri dirigenti Jared Barrera e Adam Cox. Il consiglio di amministrazione è composto da Amy Powell, Christian Robinson e Gary Seelhorst. L'offerta è stata promossa in diversi stati, tra cui California, New York, Texas, e mercati internazionali.

Kindly MD, una empresa de salud con sede en Utah enfocada en hospitales y médicos, ha presentado el Formulario D para una oferta de valores exentos bajo la Regla 506(b). La compañía ha completado con éxito una oferta de 711,7 millones de dólares, con el monto total ya vendido a 156 inversores.

Los detalles clave de la oferta incluyen:

  • Comisiones de venta de 20,6 millones de dólares y honorarios de intermediación de 293.400 dólares
  • Cohen & Company Capital Markets y Anthem Securities LLC actuando como corredores, recibiendo comisiones de capital del 2% y 0,5% respectivamente sobre las acciones ordinarias posteriores al cierre
  • La oferta incluye capital, deuda y opciones/warrants
  • Vinculada a una transacción de combinación empresarial (fusión/adquisición)

El liderazgo de la empresa incluye a Timothy Pickett como CEO y Director, con otros ejecutivos Jared Barrera y Adam Cox. La junta directiva incluye a Amy Powell, Christian Robinson y Gary Seelhorst. La oferta se comercializó en varios estados, incluyendo California, Nueva York, Texas y mercados internacionales.

Kindly MD는 유타에 본사를 둔 병원 및 의사 중심의 헬스케어 회사로, 규칙 506(b)에 따른 면제 증권 공모를 위해 Form D를 제출했습니다. 회사는 7억 1,170만 달러 규모의 공모를 성공적으로 완료했으며, 전체 금액이 이미 156명의 투자자에게 판매되었습니다.

공모의 주요 내용은 다음과 같습니다:

  • 판매 수수료 2,060만 달러 및 중개 수수료 293,400달러
  • Cohen & Company Capital Markets와 Anthem Securities LLC가 중개인으로 활동하며, 각각 종결 후 보통주에 대해 2% 및 0.5%의 지분 수수료를 받음
  • 공모에는 주식, 부채 및 옵션/워런트가 포함됨
  • 기업 결합 거래(합병/인수)와 연계

회사의 경영진에는 CEO 겸 이사인 Timothy Pickett을 비롯해 Jared Barrera와 Adam Cox가 있으며, 이사회에는 Amy Powell, Christian Robinson, Gary Seelhorst가 포함되어 있습니다. 이 공모는 캘리포니아, 뉴욕, 텍사스 및 국제 시장 등 여러 주에서 마케팅되었습니다.

Kindly MD, une société de santé basée dans l'Utah, axée sur les hôpitaux et les médecins, a déposé le formulaire D pour une offre de titres exemptée selon la règle 506(b). La société a réussi à clôturer une offre de 711,7 millions de dollars, le montant total ayant déjà été vendu à 156 investisseurs.

Les détails clés de l'offre comprennent :

  • Commissions de vente de 20,6 millions de dollars et frais d'intermédiation de 293 400 dollars
  • Cohen & Company Capital Markets et Anthem Securities LLC agissant en tant que courtiers, recevant des commissions en actions de 2 % et 0,5 % respectivement sur les actions ordinaires post-clôture
  • L'offre comprend des actions, des dettes et des options/garanties
  • Liée à une opération de fusion-acquisition

La direction de la société comprend Timothy Pickett en tant que PDG et administrateur, avec d'autres cadres Jared Barrera et Adam Cox. Le conseil d'administration inclut Amy Powell, Christian Robinson et Gary Seelhorst. L'offre a été commercialisée dans plusieurs états, notamment en Californie, à New York, au Texas, ainsi que sur des marchés internationaux.

Kindly MD, ein im US-Bundesstaat Utah ansässiges Gesundheitsunternehmen mit Fokus auf Krankenhäuser und Ärzte, hat das Formular D für ein von der Registrierung befreites Wertpapierangebot gemäß Regel 506(b) eingereicht. Das Unternehmen hat erfolgreich ein Angebot über 711,7 Millionen US-Dollar abgeschlossen, wobei der gesamte Betrag bereits an 156 Investoren verkauft wurde.

Wichtige Details des Angebots umfassen:

  • Verkaufsprovisionen in Höhe von 20,6 Millionen US-Dollar und Vermittlungsgebühren von 293.400 US-Dollar
  • Cohen & Company Capital Markets und Anthem Securities LLC fungieren als Broker und erhalten Eigenkapitalgebühren von 2 % bzw. 0,5 % des Post-Closing-Stammkapitals
  • Das Angebot umfasst Eigenkapital, Schulden sowie Optionen/Warrants
  • Im Zusammenhang mit einer Unternehmenszusammenschluss-Transaktion (Fusion/Übernahme)

Die Unternehmensführung besteht aus Timothy Pickett als CEO und Direktor sowie weiteren Führungskräften Jared Barrera und Adam Cox. Der Vorstand setzt sich aus Amy Powell, Christian Robinson und Gary Seelhorst zusammen. Das Angebot wurde in mehreren Bundesstaaten, darunter Kalifornien, New York, Texas, sowie auf internationalen Märkten beworben.

The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.
The reader should not assume that the information is accurate and complete.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM D

Notice of Exempt Offering of Securities

OMB APPROVAL
OMB Number: 3235-0076
Estimated average burden
hours per response: 4.00

1. Issuer's Identity

CIK (Filer ID Number) Previous Names
None
Entity Type
0001946573
Utah Therapeutic Health Center, PLLC
Utah Therapeutic Health Center, LLC
X Corporation
Limited Partnership
Limited Liability Company
General Partnership
Business Trust
Other (Specify)

Name of Issuer
Kindly MD, Inc.
Jurisdiction of Incorporation/Organization
UTAH
Year of Incorporation/Organization
X Over Five Years Ago
Within Last Five Years (Specify Year)
Yet to Be Formed

2. Principal Place of Business and Contact Information

Name of Issuer
Kindly MD, Inc.
Street Address 1 Street Address 2
5097 SOUTH 900 EAST, SUITE 100
City State/Province/Country ZIP/PostalCode Phone Number of Issuer
SALT LAKE CITY UTAH 84117 (385) 388-8220

3. Related Persons

Last Name First Name Middle Name
Pickett Timothy
Street Address 1 Street Address 2
5097 South 900 East, Suite 100
City State/Province/Country ZIP/PostalCode
Salt Lake City UTAH 84117
Relationship: X Executive Officer X Director Promoter

Clarification of Response (if Necessary):


Last Name First Name Middle Name
Barrera Jared
Street Address 1 Street Address 2
5097 South 900 East, Suite 100
City State/Province/Country ZIP/PostalCode
Salt Lake City UTAH 84117
Relationship: X Executive Officer Director Promoter

Clarification of Response (if Necessary):


Last Name First Name Middle Name
Cox Adam
Street Address 1 Street Address 2
5097 South 900 East, Suite 100
City State/Province/Country ZIP/PostalCode
Salt Lake City UTAH 84117
Relationship: X Executive Officer X Director Promoter

Clarification of Response (if Necessary):


Last Name First Name Middle Name
Powell Amy
Street Address 1 Street Address 2
5097 South 900 East, Suite 100
City State/Province/Country ZIP/PostalCode
Salt Lake City UTAH 84117
Relationship: Executive Officer X Director Promoter

Clarification of Response (if Necessary):


Last Name First Name Middle Name
Robinson Christian
Street Address 1 Street Address 2
5097 South 900 East, Suite 100
City State/Province/Country ZIP/PostalCode
Salt Lake City UTAH 84117
Relationship: Executive Officer X Director Promoter

Clarification of Response (if Necessary):


Last Name First Name Middle Name
Seelhorst Gary
Street Address 1 Street Address 2
5097 South 900 East, Suite 100
City State/Province/Country ZIP/PostalCode
Salt Lake City UTAH 84117
Relationship: Executive Officer X Director Promoter

Clarification of Response (if Necessary):


4. Industry Group

Agriculture
Banking & Financial Services
Commercial Banking
Insurance
Investing
Investment Banking
Pooled Investment Fund
Is the issuer registered as
an investment company under
the Investment Company
Act of 1940?
Yes No
Other Banking & Financial Services
Business Services
Energy
Coal Mining
Electric Utilities
Energy Conservation
Environmental Services
Oil & Gas
Other Energy
Health Care
Biotechnology
Health Insurance
X Hospitals & Physicians
Pharmaceuticals
Other Health Care
Manufacturing
Real Estate
Commercial
Construction
REITS & Finance
Residential
Other Real Estate
Retailing
Restaurants
Technology
Computers
Telecommunications
Other Technology
Travel
Airlines & Airports
Lodging & Conventions
Tourism & Travel Services
Other Travel
Other

5. Issuer Size

Revenue Range OR Aggregate Net Asset Value Range
No Revenues No Aggregate Net Asset Value
$1 - $1,000,000 $1 - $5,000,000
$1,000,001 - $5,000,000 $5,000,001 - $25,000,000
$5,000,001 - $25,000,000 $25,000,001 - $50,000,000
$25,000,001 - $100,000,000 $50,000,001 - $100,000,000
Over $100,000,000 Over $100,000,000
X Decline to Disclose Decline to Disclose
Not Applicable Not Applicable

6. Federal Exemption(s) and Exclusion(s) Claimed (select all that apply)

Rule 504(b)(1) (not (i), (ii) or (iii))
Rule 504 (b)(1)(i)
Rule 504 (b)(1)(ii)
Rule 504 (b)(1)(iii)
X Rule 506(b)
Rule 506(c)
Securities Act Section 4(a)(5)
Investment Company Act Section 3(c)
Section 3(c)(1) Section 3(c)(9)
Section 3(c)(2) Section 3(c)(10)
Section 3(c)(3) Section 3(c)(11)
Section 3(c)(4) Section 3(c)(12)
Section 3(c)(5) Section 3(c)(13)
Section 3(c)(6) Section 3(c)(14)
Section 3(c)(7)

7. Type of Filing

X New Notice Date of First Sale 2025-05-13 First Sale Yet to Occur
Amendment

8. Duration of Offering

Does the Issuer intend this offering to last more than one year?
Yes X No

9. Type(s) of Securities Offered (select all that apply)

X Equity Pooled Investment Fund Interests
X Debt Tenant-in-Common Securities
X Option, Warrant or Other Right to Acquire Another Security Mineral Property Securities
Security to be Acquired Upon Exercise of Option, Warrant or Other Right to Acquire Security Other (describe)

10. Business Combination Transaction

Is this offering being made in connection with a business combination transaction, such as a merger, acquisition or exchange offer?
X Yes No

Clarification of Response (if Necessary):

11. Minimum Investment

Minimum investment accepted from any outside investor $0 USD

12. Sales Compensation

Recipient
Recipient CRD Number None
Cohen & Company Capital Markets 000144981
(Associated) Broker or Dealer None
(Associated) Broker or Dealer CRD Number None
J.V.B. Financial Group, LLC 000104412
Street Address 1 Street Address 2
3 Columbus Circle, 24th FL
City State/Province/Country ZIP/Postal Code
New York NEW YORK 10019
State(s) of Solicitation (select all that apply)
Check "All States" or check individual States
All States
X Foreign/non-US
CALIFORNIA
CONNECTICUT
FLORIDA
ILLINOIS
MICHIGAN
NEW JERSEY
NEW YORK
TEXAS
UTAH
WYOMING

Recipient
Recipient CRD Number None
Anthem Securities LLC 000298454
(Associated) Broker or Dealer None
(Associated) Broker or Dealer CRD Number None
10X Securities 000104410
Street Address 1 Street Address 2
One World Trade Center, FL85
City State/Province/Country ZIP/Postal Code
New York NEW YORK 10007
State(s) of Solicitation (select all that apply)
Check "All States" or check individual States
All States
X Foreign/non-US
CALIFORNIA
FLORIDA
MINNESOTA
NEBRASKA
NEVADA
NEW HAMPSHIRE
TEXAS
WASHINGTON

13. Offering and Sales Amounts

Total Offering Amount $711,694,558 USD
or Indefinite
Total Amount Sold $711,694,558 USD
Total Remaining to be Sold $0 USD
or Indefinite

Clarification of Response (if Necessary):

14. Investors

Select if securities in the offering have been or may be sold to persons who do not qualify as accredited investors, and enter the number of such non-accredited investors who already have invested in the offering.
Regardless of whether securities in the offering have been or may be sold to persons who do not qualify as accredited investors, enter the total number of investors who already have invested in the offering:
156

15. Sales Commissions & Finder's Fees Expenses

Provide separately the amounts of sales commissions and finders fees expenses, if any. If the amount of an expenditure is not known, provide an estimate and check the box next to the amount.

Sales Commissions $20,636,596 USD
Estimate
Finders' Fees $293,400 USD
Estimate

Clarification of Response (if Necessary):

Cohen & Company Capital Markets and Anthem Securities LLC are also entitled to equity fees in an amount equal to 2% and 0.5%, respectively, of the post-closing company's common stock.

16. Use of Proceeds

Provide the amount of the gross proceeds of the offering that has been or is proposed to be used for payments to any of the persons required to be named as executive officers, directors or promoters in response to Item 3 above. If the amount is unknown, provide an estimate and check the box next to the amount.

$0 USD
Estimate

Clarification of Response (if Necessary):

Signature and Submission

Please verify the information you have entered and review the Terms of Submission below before signing and clicking SUBMIT below to file this notice.

Terms of Submission

In submitting this notice, each issuer named above is:
  • Notifying the SEC and/or each State in which this notice is filed of the offering of securities described and undertaking to furnish them, upon written request, in the accordance with applicable law, the information furnished to offerees.*
  • Irrevocably appointing each of the Secretary of the SEC and, the Securities Administrator or other legally designated officer of the State in which the issuer maintains its principal place of business and any State in which this notice is filed, as its agents for service of process, and agreeing that these persons may accept service on its behalf, of any notice, process or pleading, and further agreeing that such service may be made by registered or certified mail, in any Federal or state action, administrative proceeding, or arbitration brought against the issuer in any place subject to the jurisdiction of the United States, if the action, proceeding or arbitration (a) arises out of any activity in connection with the offering of securities that is the subject of this notice, and (b) is founded, directly or indirectly, upon the provisions of: (i) the Securities Act of 1933, the Securities Exchange Act of 1934, the Trust Indenture Act of 1939, the Investment Company Act of 1940, or the Investment Advisers Act of 1940, or any rule or regulation under any of these statutes, or (ii) the laws of the State in which the issuer maintains its principal place of business or any State in which this notice is filed.
  • Certifying that, if the issuer is claiming a Regulation D exemption for the offering, the issuer is not disqualified from relying on Rule 504 or Rule 506 for one of the reasons stated in Rule 504(b)(3) or Rule 506(d).

Each Issuer identified above has read this notice, knows the contents to be true, and has duly caused this notice to be signed on its behalf by the undersigned duly authorized person.

For signature, type in the signer's name or other letters or characters adopted or authorized as the signer's signature.

Issuer Signature Name of Signer Title Date
Kindly MD, Inc. /s/ Timothy Pickett Timothy Pickett Chief Executive Officer 2025-06-25

Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB number.

* This undertaking does not affect any limits Section 102(a) of the National Securities Markets Improvement Act of 1996 ("NSMIA") [Pub. L. No. 104-290, 110 Stat. 3416 (Oct. 11, 1996)] imposes on the ability of States to require information. As a result, if the securities that are the subject of this Form D are "covered securities" for purposes of NSMIA, whether in all instances or due to the nature of the offering that is the subject of this Form D, States cannot routinely require offering materials under this undertaking or otherwise and can require offering materials only to the extent NSMIA permits them to do so under NSMIA's preservation of their anti-fraud authority.


FAQ

What is the total offering amount for NAKA's Form D filing on June 28, 2025?

According to the Form D filing, NAKA (Kindly MD, Inc.) reported a total offering amount of $711,694,558 USD, which has been fully sold with $0 remaining to be sold.

Who are the key executive officers and directors of NAKA as disclosed in the Form D?

The key personnel disclosed include: Timothy Pickett (Executive Officer and Director), Jared Barrera (Executive Officer), Adam Cox (Executive Officer and Director), Amy Powell (Director), Christian Robinson (Director), and Gary Seelhorst (Director).

What are the sales compensation details for NAKA's Form D offering?

The sales compensation includes $20,636,596 in sales commissions and $293,400 in finder's fees. Additionally, Cohen & Company Capital Markets and Anthem Securities LLC are entitled to equity fees of 2% and 0.5% respectively of the post-closing company's common stock.

How many investors participated in NAKA's Form D offering?

The Form D filing indicates that 156 investors have already invested in the offering.

What type of securities did NAKA offer in this Form D filing?

NAKA offered multiple types of securities including Equity, Debt, and Options/Warrants or Other Rights to Acquire Another Security. The offering is being made in connection with a business combination transaction.
Kindly Md, Inc.

NASDAQ:NAKA

NAKA Rankings

NAKA Latest News

NAKA Latest SEC Filings

NAKA Stock Data

121.59M
3.92M
Services-health Services
SALT LAKE CITY